La bourse ferme dans 5 h 48 min

Stryker Corporation (SYK)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
358,71+9,13 (+2,61 %)
À la clôture : 04:00PM EDT
359,30 +0,59 (+0,16 %)
Avant Bourse : 04:09AM EDT

Stryker Corporation

1941 Stryker Way
Portage, MI 49002
United States
269 385 2600
https://www.stryker.com

Secteur(s)Healthcare
Secteur d’activitéMedical Devices
Employés à temps plein52 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Kevin A. LoboChairman, CEO & President3,31M33,14M1965
Mr. Glenn S. BoehnleinVP & CFO1,43MS.O.1962
Mr. Viju S. MenonGroup President of Global Quality & Operations1,05MS.O.1968
Mr. J. Andrew PierceGroup President of MedSurg & Neurotechnology1,32MS.O.1974
Mr. Spencer S. StilesGroup President of Orthopaedics & Spine1,28M2,13M1977
Mr. William E. Berry Jr.VP & Chief Accounting OfficerS.O.S.O.1966
Mr. Robert C. CohenCTO and VP of Global R&D - Joint ReplacementS.O.S.O.S.O.
Mr. Alan DouvilleVP, Chief Information Officer & Chief Information Security OfficerS.O.S.O.S.O.
Mr. Jason BeachVice President of Investor RelationsS.O.S.O.S.O.
Mr. Robert S. FletcherVP & Chief Legal Officer895,89kS.O.1971
Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Stryker Corporation en date du 1 mars 2024 est 6. Les scores principaux sont Audit : 7; Société : 5; Droits des actionnaires : 6; Compensation : 5.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.